Delta-Fly Pharma Overview
Valuation check: 4598.T's PEG ratio is -4.81, below the Healthcare sector average of 11.77.
Get informed when a big investor buys or sells
+ Follow-4.81
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for 4598.T is -4.81. That is below the Healthcare sector average of 11.77. Investors often review this figure alongside Delta-Fly Pharma's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, 4598.T currently prints -4.81 for PEG ratio, while the sector average sits near 11.77. That is roughly 140.9% below the sector mean. Large gaps often invite a closer look at Delta-Fly Pharma's growth, margins, and balance sheet.
A PEG ratio of -4.81 for Delta-Fly Pharma is not 'good' or 'bad' on its own. Compare it with the peer average (11.77) and with 4598.T's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting 4598.T's PEG ratio (-4.81), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Delta-Fly Pharma's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
